Please assess the completion status of the following clinical trial:

Trial Title: Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of hormone-receptor positive early breast cancer~* Menopausal status~* Age \< 75 years~* Written informed consent~Exclusion Criteria:~* Premenopausal status at time of randomization~* Comorbidities with increased risk of osteoporosis (primary hyperparathyroidism, hyperthyroidism, rheumatoid arthritis)~* BMI \< 18~* Chronic use of steroids~* Use of bisphosphonates at time of randomization~* Psychiatric disorders

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Arm A: Ibandronic acid (Type: EXPERIMENTAL): Ibandronic acid 150 mg per os per month for two years
- Arm B: Placebo (Type: PLACEBO_COMPARATOR): Placebo per os per month for two years

Based on this trial design, predict the completion outcome and termination type (if applicable).